Arthur T Knackerbracket has found the following story:
An immunotherapy drug has been described as a potential "game-changer" in promising results presented at the European Cancer Congress.
In a study of head and neck cancer, more patients taking nivolumab survived for longer compared with those who were treated with chemotherapy. In another study, combining nivolumab with another drug shrank tumours in advanced kidney cancer patients.
Immunotherapy works by harnessing the immune system to destroy cancer cells.
Advanced head and neck cancer has very poor survival rates.
In a trial of more than 350 patients, published in the New England Journal of Medicine, 36% treated with the immunotherapy drug nivolumab were alive after one year compared with 17% who received chemotherapy. Patients also experienced fewer side effects from immunotherapy.
The benefits were more pronounced in patients whose tumours had tested positive for HPV (human papillomavirus). These patients survived an average of 9.1 months with nivolumab and 4.4 months with chemotherapy.
Normally, this group of patients, with advanced or treatment-resistant tumours, are expected to live less than six months.
Early data from a study of 94 patients with advanced kidney cancer showed that the double hit of nivolumab and ipilimumab resulted in a significant reduction in the size of tumours in 40% of patients. Of these patients, one in 10 had no sign of cancer remaining. This compares with 5% of patients showing tumour reduction after standard therapy.
[...] As yet, nivolumab has only been approved for treating skin cancer and in June it became one of the fastest medicines ever approved for NHS use, in combination with ipilimumab, for the same cancer. Nivolumab and ipilimumab both work by interrupting the chemical signals that cancers use to convince the immune system they are healthy tissue.
(Score: 2) by sjames on Tuesday October 11 2016, @04:40PM
Actually, it's a great metric if you want to know how crazy overpriced something is. In the case of Altavera, it just happens that you need so little it's affordable in spite of being marked up to crazy heights.
(Score: 0) by Anonymous Coward on Tuesday October 11 2016, @04:59PM
Get back to us when there is a standard dose for gold medication.
(Score: 2) by sjames on Wednesday October 12 2016, @04:00AM
OK [wikipedia.org]